These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25865117)

  • 1. In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA.
    Erratico C; Negreira N; Norouzizadeh H; Covaci A; Neels H; Maudens K; van Nuijs AL
    Drug Test Anal; 2015 Oct; 7(10):866-76. PubMed ID: 25865117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry.
    Presley BC; Logan BK; Jansen-Varnum SA
    Drug Test Anal; 2019 Aug; 11(8):1264-1276. PubMed ID: 31108568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UPLC-HR-MS/MS-based determination study on the metabolism of four synthetic cannabinoids, ADB-FUBICA, AB-FUBICA, AB-BICA and ADB-BICA, by human liver microsomes.
    Li J; Liu C; Li T; Hua Z
    Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 28992356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of AB-CHMINACA and its metabolites in human hair and their deposition in hair of abusers.
    Sim J; Cho HS; Lee J; In S; Kim E
    J Pharm Biomed Anal; 2017 Jun; 140():162-168. PubMed ID: 28359963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and quantification of predominant metabolites of synthetic cannabinoid MAB-CHMINACA in an authentic human urine specimen.
    Hasegawa K; Minakata K; Gonmori K; Nozawa H; Yamagishi I; Watanabe K; Suzuki O
    Drug Test Anal; 2018 Feb; 10(2):365-371. PubMed ID: 28560823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes.
    Carlier J; Diao X; Sempio C; Huestis MA
    AAPS J; 2017 Mar; 19(2):568-577. PubMed ID: 28070717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Metabolic Profile Elucidation of Synthetic Cannabinoid APP-CHMINACA (PX-3).
    Presley BC; Logan BK; Jansen-Varnum SA
    J Anal Toxicol; 2020 Apr; 44(3):226-236. PubMed ID: 31665324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Identification of MDMB-CHMINACA Metabolites Using Zebrafish and Human Liver Microsomes as the Biotransformation System by LC-QE-HF-MS.
    Xu DQ; Dai Y; Zhang WF; Wang JF; Wang YY; Zhang Y; Zhao QL; Li X
    J Anal Toxicol; 2021 Jan; 44(9):1012-1026. PubMed ID: 32020177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome.
    Takayama T; Suzuki M; Todoroki K; Inoue K; Min JZ; Kikura-Hanajiri R; Goda Y; Toyo'oka T
    Biomed Chromatogr; 2014 Jun; 28(6):831-8. PubMed ID: 24861751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of metabolites of the new synthetic cannabinoid CUMYL-4CN-BINACA in authentic urine samples and human liver microsomes using high-resolution mass spectrometry.
    Öztürk YE; Yeter O; Öztürk S; Karakus G; Ates I; Buyuk Y; Yurdun T
    Drug Test Anal; 2018 Mar; 10(3):449-459. PubMed ID: 28691766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of an indazole-3-carboxamide class synthetic cannabinoid: 2-[1-(cyclohexylmethyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoic acid (DMBA-CHMINACA).
    Lee JH; Jung A; Park HN; Lee C; Mandava S; Lim SJ; Lim BB; Park SK; Lee J; Kang H
    Forensic Sci Int; 2018 Oct; 291():167-174. PubMed ID: 30216842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and quantification of metabolites of AB-CHMINACA in a urine specimen of an abuser.
    Wurita A; Hasegawa K; Minakata K; Gonmori K; Nozawa H; Yamagishi I; Suzuki O; Watanabe K
    Leg Med (Tokyo); 2016 Mar; 19():113-8. PubMed ID: 26257317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry.
    Holm NB; Pedersen AJ; Dalsgaard PW; Linnet K
    Drug Test Anal; 2015 Mar; 7(3):199-206. PubMed ID: 24802286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA.
    Wohlfarth A; Castaneto MS; Zhu M; Pang S; Scheidweiler KB; Kronstrand R; Huestis MA
    AAPS J; 2015 May; 17(3):660-77. PubMed ID: 25721194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometric identification of in vitro-generated metabolites of two emerging organophosphate flame retardants: V6 and BDP.
    Alves A; Erratico C; Lucattini L; Cuykx M; Ballesteros-Gómez A; Leonards PEG; Voorspoels S; Covaci A
    Chemosphere; 2018 Dec; 212():1047-1057. PubMed ID: 30286534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubation.
    Gaunitz F; Thomas A; Fietzke M; Franz F; Auwärter V; Thevis M; Mercer-Chalmers-Bender K
    Int J Legal Med; 2019 Jul; 133(4):1049-1064. PubMed ID: 30564916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS).
    Steuer AE; Williner E; Staeheli SN; Kraemer T
    Drug Test Anal; 2017 Jul; 9(7):1085-1092. PubMed ID: 27736030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA.
    Tyndall JA; Gerona R; De Portu G; Trecki J; Elie MC; Lucas J; Slish J; Rand K; Bazydlo L; Holder M; Ryan MF; Myers P; Iovine N; Plourde M; Weeks E; Hanley JR; Endres G; St Germaine D; Dobrowolski PJ; Schwartz M
    Clin Toxicol (Phila); 2015; 53(10):950-6. PubMed ID: 26555732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suspect and non-target screening workflows to investigate the in vitro and in vivo metabolism of the synthetic cannabinoid 5Cl-THJ-018.
    Vervliet P; Mortelé O; Gys C; Degreef M; Lanckmans K; Maudens K; Covaci A; van Nuijs ALN; Lai FY
    Drug Test Anal; 2019 Mar; 11(3):479-491. PubMed ID: 30242979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
    Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.